Assessment of nail fold capillary changes by hand-held dermoscopy in adult dermatomyositis: A single-centre prospective study.


Journal

The Australasian journal of dermatology
ISSN: 1440-0960
Titre abrégé: Australas J Dermatol
Pays: Australia
ID NLM: 0135232

Informations de publication

Date de publication:
Nov 2023
Historique:
revised: 13 08 2023
received: 08 12 2022
accepted: 31 08 2023
medline: 10 11 2023
pubmed: 19 9 2023
entrez: 19 9 2023
Statut: ppublish

Résumé

Hand-held dermoscopy is a valuable tool for dermatologists, but it has been rarely used to assess the nail fold capillary (NFC) in patients with dermatomyositis (DM). Patients were collected from the Department of Dermatology and Venereology from July 2020 to July 2021, and the follow-up was conducted until January 2022. Demographic features, disease activity and NFC changes were analysed using a hand-held dermoscopy. The most common NFC finding in our study was bushy capillary (87.0%). There was no significant improvement in scleroderma-dermatomyositis (SD)-like nail fold changes or enlarged capillaries from baseline to 12 weeks of treatment (p > 0.05) or from 12 weeks to 24 weeks of treatment (p > 0.05), but there was a significant improvement from baseline to 24 weeks of treatment (p < 0.05). The avascular area did not improve from baseline to 12 weeks of follow-up, but the changes were significant from 12 weeks to 24 weeks of treatment (p < 0.05) and baseline to 24 weeks of treatment (p < 0.05). Periungual erythema improved significantly from baseline to 12 weeks of treatment (p < 0.05) and baseline to 24 weeks of treatment (p < 0.05), but it did not improve significantly from 12 weeks to 24 weeks of treatment (p > 0.05). There was no significant difference in disease activity between patients with or without specific NFC changes. However, some NFC features improved as disease activity decreased. Dermoscopy of NFC is a cost-effective option for the preliminary diagnosis of DM. Further, long-term follow-up is necessary to study the relationship between disease activity and NFC changes.

Sections du résumé

BACKGROUND BACKGROUND
Hand-held dermoscopy is a valuable tool for dermatologists, but it has been rarely used to assess the nail fold capillary (NFC) in patients with dermatomyositis (DM).
METHODS METHODS
Patients were collected from the Department of Dermatology and Venereology from July 2020 to July 2021, and the follow-up was conducted until January 2022. Demographic features, disease activity and NFC changes were analysed using a hand-held dermoscopy.
RESULTS RESULTS
The most common NFC finding in our study was bushy capillary (87.0%). There was no significant improvement in scleroderma-dermatomyositis (SD)-like nail fold changes or enlarged capillaries from baseline to 12 weeks of treatment (p > 0.05) or from 12 weeks to 24 weeks of treatment (p > 0.05), but there was a significant improvement from baseline to 24 weeks of treatment (p < 0.05). The avascular area did not improve from baseline to 12 weeks of follow-up, but the changes were significant from 12 weeks to 24 weeks of treatment (p < 0.05) and baseline to 24 weeks of treatment (p < 0.05). Periungual erythema improved significantly from baseline to 12 weeks of treatment (p < 0.05) and baseline to 24 weeks of treatment (p < 0.05), but it did not improve significantly from 12 weeks to 24 weeks of treatment (p > 0.05). There was no significant difference in disease activity between patients with or without specific NFC changes. However, some NFC features improved as disease activity decreased.
CONCLUSION CONCLUSIONS
Dermoscopy of NFC is a cost-effective option for the preliminary diagnosis of DM. Further, long-term follow-up is necessary to study the relationship between disease activity and NFC changes.

Identifiants

pubmed: 37723903
doi: 10.1111/ajd.14157
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

514-521

Subventions

Organisme : Natural Science Foundation of Sichuan
ID : 2022NSFC0713

Informations de copyright

© 2023 Australasian College of Dermatologists.

Références

Callen JP. Dermatomyositis. Lancet. 2000;355(9197):53-57. https://doi.org/10.1016/s0140-6736(99)05157-0
Argenziano G, Soyer HP, Chimenti S, Talamini R, Corona R, Sera F, et al. Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet. J Am Acad Dermatol. 2003;48(5):679-693. https://doi.org/10.1067/mjd.2003.281
Soyer HP, Argenziano G, Chimenti S, Ruocco V. Dermoscopy of pigmented skin lesions. Eur J Dermatol. 2001;11(3):270-276; quiz 7.
Mugii N, Hasegawa M, Matsushita T, Hamaguchi Y, Horie S, Yahata T, et al. Association between nail-fold capillary findings and disease activity in dermatomyositis. Rheumatology. 2011;50(6):1091-1098. https://doi.org/10.1093/rheumatology/keq430
Smith RL, Sundberg J, Shamiyah E, Dyer A, Pachman LM. Skin involvement in juvenile dermatomyositis is associated with loss of end row nailfold capillary loops. J Rheumatol. 2004;31(8):1644-1649.
Bergman R, Sharony L, Schapira D, Nahir MA, Balbir-Gurman A. The handheld dermatoscope as a nail-fold capillaroscopic instrument. Arch Dermatol. 2003;139(8):1027-1030. https://doi.org/10.1001/archderm.139.8.1027
Sontheimer RD. A portable digital microphotography unit for rapid documentation of periungual nailfold capillary changes in autoimmune connective tissue diseases. J Rheumatol. 2004;31(3):539-544.
Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292(7):344-347. https://doi.org/10.1056/NEJM197502132920706
Sontheimer RD. Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects. Dermatol Clin. 2002;20(3):387-408. https://doi.org/10.1016/s0733-8635(02)00021-9
von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453-1457. https://doi.org/10.1016/S0140-6736(07)61602-X
Maricq HR. Wide-field capillary microscopy. Arthritis Rheum. 1981;24(9):1159-1165. https://doi.org/10.1002/art.1780240907
Miossi R, de Souza FHC, Shinjo SK. Nailfold capillary changes in adult new-onset dermatomyositis: a prospective cross-sectional study. Clin Rheumatol. 2019;38(9):2319-2326. https://doi.org/10.1007/s10067-019-04537-x
Tosti A. The nail apparatus in collagen disorders. Semin Dermatol. 1991;10(1):71-76.
Bertolazzi C, Cutolo M, Smith V, Gutierrez M. State of the art on nailfold capillaroscopy in dermatomyositis and polymyositis. Semin Arthritis Rheum. 2017;47(3):432-444. https://doi.org/10.1016/j.semarthrit.2017.06.001
Beltran E, Toll A, Pros A, Carbonell J, Pujol RM. Assessment of nailfold capillaroscopy by x 30 digital epiluminescence (dermoscopy) in patients with Raynaud phenomenon. Br J Dermatol. 2007;156(5):892-898. https://doi.org/10.1111/j.1365-2133.2007.07819.x
Baron M, Bell M, Bookman A, Buchignani M, Dunne J, Hudson M, et al. Office capillaroscopy in systemic sclerosis. Clin Rheumatol. 2007;26(8):1268-1274. https://doi.org/10.1007/s10067-006-0489-6
Blockmans D, Beyens G, Verhaeghe R. Predictive value of nailfold capillaroscopy in the diagnosis of connective tissue diseases. Clin Rheumatol. 1996;15(2):148-153. https://doi.org/10.1007/BF02230332
Shenavandeh S, Zarei Nezhad M. Association of nailfold capillary changes with disease activity, clinical and laboratory findings in patients with dermatomyositis. Med J Islam Repub Iran. 2015;29:233.
Chanprapaph K, Fakprapai W, Limtong P, Suchonwanit P. Nailfold capillaroscopy with USB digital microscopy in connective tissue diseases: a comparative study of 245 patients and healthy controls. Front Med (Lausanne). 2021;8:683900. https://doi.org/10.3389/fmed.2021.683900
Samitz MH. Cuticular changes in dermatomyositis. A clinical sign. Arch Dermatol. 1974;110(6):866-867.
Ekmekci TR, Ucak S, Aslan K, Koslu A, Altuntas Y. Exaggerated cuticular changes in a patient with dermatomyositis. J Eur Acad Dermatol Venereol. 2005;19(1):135-136. https://doi.org/10.1111/j.1468-3083.2004.00990.x
Manfredi A, Sebastiani M, Cassone G, Pipitone N, Giuggioli D, Colaci M, et al. Nailfold capillaroscopic changes in dermatomyositis and polymyositis. Clin Rheumatol. 2015;34(2):279-284. https://doi.org/10.1007/s10067-014-2795-8
Selva-O'Callaghan A, Fonollosa-Pla V, Trallero-Araguas E, Martinez-Gomez X, Simeon-Aznar CP, Labrador-Horrillo M, et al. Nailfold capillary microscopy in adults with inflammatory myopathy. Semin Arthritis Rheum. 2010;39(5):398-404. https://doi.org/10.1016/j.semarthrit.2008.09.003
Cutolo M, Pizzorni C, Sulli A. Capillaroscopy. Best Pract Res Clin Rheumatol. 2005;19(3):437-452. https://doi.org/10.1016/j.berh.2005.01.001
Bauersachs RM, Lossner F. The poor man's capillary microscope. A novel technique for the assessment of capillary morphology. Ann Rheum Dis. 1997;56(7):435-437. https://doi.org/10.1136/ard.56.7.435
Zalaudek I, Argenziano G, Di Stefani A, Ferrara G, Marghoob AA, Hofmann-Wellenhof R, et al. Dermoscopy in general dermatology. Dermatology. 2006;212(1):7-18. https://doi.org/10.1159/000089015
Grover C, Jakhar D. Hand-held dermatoscope or videodermatoscope: which one to buy? Indian J Dermatol Venereol Leprol. 2021;87(5):739-741. https://doi.org/10.25259/IJDVL_802_19
Schmeling H, Stephens S, Goia C, Manlhiot C, Schneider R, Luthra S, et al. Nailfold capillary density is importantly associated over time with muscle and skin disease activity in juvenile dermatomyositis. Rheumatology. 2011;50(5):885-893. https://doi.org/10.1093/rheumatology/keq407

Auteurs

Aliza Paudyal (A)

Department of Dermatology and Venereology, West China Hospital, Sichuan University, Chengdu, China.
Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
Department of Dermatology and Venereology, B.P. Koirala Institute of Health Sciences, Dharan, Nepal.

Yao Yang (Y)

Department of Dermatology and Venereology, West China Hospital, Sichuan University, Chengdu, China.
Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.

Ming Zheng (M)

Department of Dermatology and Venereology, West China Hospital, Sichuan University, Chengdu, China.
Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.

Xingwei Zhang (X)

Department of Dermatology and Venereology, West China Hospital, Sichuan University, Chengdu, China.
Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.

Han Wang (H)

Department of Dermatology and Venereology, West China Hospital, Sichuan University, Chengdu, China.
Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.

Shirui Gong (S)

Department of Dermatology and Venereology, West China Hospital, Sichuan University, Chengdu, China.
Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.

Parbatraj Regmi (P)

Department of Dermatology and Venereology, West China Hospital, Sichuan University, Chengdu, China.
Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.

Xiaoyan Lyu (X)

Department of Dermatology and Venereology, West China Hospital, Sichuan University, Chengdu, China.
Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH